HCW Biologics Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: HCW Biologics Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
HCW Biologics Inc. Assets for the quarter ending September 30, 2024 was $26.6M, a 25.4% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$26.6M	-$9.06M	-25.4%	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$26.8M	-$12.7M	-32.1%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$30.4M	-$13.1M	-30.1%	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$28.5M	-$18.3M	-39.1%	Dec 31, 2023	10-Q	2024-11-14
Q3 2023	$35.6M	-$15.7M	-30.6%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$39.5M	-$7.93M	-16.7%	Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$43.5M	-$7.42M	-14.6%	Mar 31, 2023	10-Q/A	2023-08-10
Q4 2022	$46.8M	-$6.71M	-12.5%	Dec 31, 2022	10-K/A	2024-05-15
Q3 2022	$51.4M	-$5.05M	-8.96%	Sep 30, 2022	10-Q	2022-11-07
Q2 2022	$47.4M	+$34.4M	+264%	Jun 30, 2022	10-Q	2022-08-12
Q1 2022	$51M			Mar 31, 2022	10-Q	2022-05-13
Q4 2021	$53.5M	+$38.1M	+248%	Dec 31, 2021	10-K	2023-03-28
Q3 2021	$56.4M			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$13M			Jun 30, 2021	10-Q	2021-08-13
Q4 2020	$15.4M			Dec 31, 2020	10-K	2022-03-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.